UASp regulatory sequences drive expression of Cdc42 that carries a R186C amino acid replacement. This change is in a highly conserved residue and is equivalent to an identical (R186C) change in the orthologous human CDC42 gene, a variant identified in patients with infantile myelofibrosis.